REGENERON PHARMACEUTICALS, INC.
data from 30/09/2025
Capitalization
$ 700.445 M
-52.83 %
Performance
$ 1.004 B
74.47 %
| Date | Ticket | Name | Weight | Capitalization | Share number | First added | Performance ($) | Performance (%) |
|---|---|---|---|---|---|---|---|---|
| 2025/09/30 | ALNY | Alnylam Pharmaceuticals, Inc. | 90.64% | 634.890 M $ | 1392303 | 2024/12/31 | 577.378 M $ | 39.84 % |
| 2025/09/30 | NTLA | Intellia Therapeutics, Inc. | 9.13% | 63.951 M $ | 3702995 | 2024/12/31 | 29.217 M $ | 84.12 % |
| 2025/09/30 | ADVM | Adverum Biotechnologies, Inc. | 0.12% | 819.518 K $ | 180909 | 2024/12/31 | 430.563 K $ | 110.70 % |
| 2025/09/30 | ACET | Adicet Bio, Inc. | 0.11% | 784.422 K $ | 968183 | 2024/12/31 | 193.830 K $ | 32.82 % |